Presentation_1_Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.PDF by David Grünig (3704716)

“…Tamoxifen and WIN 55,212-2 decreased cellular ApoB-100 excretion. In conclusion, the established inhibitors of fatty acid metabolism caused the expected effects in HepG2 cells. …”

Image_2_Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.TIF by David Grünig (3704716)

“…Tamoxifen and WIN 55,212-2 decreased cellular ApoB-100 excretion. In conclusion, the established inhibitors of fatty acid metabolism caused the expected effects in HepG2 cells. …”

Image_4_Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.TIF by David Grünig (3704716)

“…Tamoxifen and WIN 55,212-2 decreased cellular ApoB-100 excretion. In conclusion, the established inhibitors of fatty acid metabolism caused the expected effects in HepG2 cells. …”

Image_1_Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.TIF by David Grünig (3704716)

“…Tamoxifen and WIN 55,212-2 decreased cellular ApoB-100 excretion. In conclusion, the established inhibitors of fatty acid metabolism caused the expected effects in HepG2 cells. …”

Image_3_Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.TIF by David Grünig (3704716)

“…Tamoxifen and WIN 55,212-2 decreased cellular ApoB-100 excretion. In conclusion, the established inhibitors of fatty acid metabolism caused the expected effects in HepG2 cells. …”

Effect of perchloric acid concentration (indicated in the figure – mol L⁻¹) in the clock time. by Rafaela T. P. Sant'Anna (502388)

Development of a range of fluorescent reagentless biosensors for ATP, based on malonyl-coenzyme A synthetase by Renée Vancraenenbroeck (139242)

“…These variants widen the range of ATP concentration that can be measured readily by this biosensor to >100 μM. In contrast, a third variant, S170A, decreased the dissociation constant of ATP to 3.8 μM and has a fluorescence change of 4.2 on binding ATP. …”

SIE allows only a small region of coinfection when 2 established regions of IAV infection meet. by Anna Sims (14592855)

Image 5_Global burden of varicella and herpes zoster across 204 countries, 1990–2021: a temporal trend analysis in the era of the COVID-19 pandemic and projections to 2036.tiff by Zilun Wu (18696883)

“…Joinpoint regression analysis identified significant shifts in temporal trends, treating 2019 as a key inflection point to observe the pandemic’s impact. …”

Joint moment data from the lower limb joints. by Eric Yung-Sheng Su (13015474)

Lesion formation of a <i>B</i>. <i>cinerea bot2 boa6</i> double mutant on different host tissues. by Thomas Leisen (9248883)

Lesion formation of a <i>B</i>. <i>cinerea pg1 pg2</i> double mutant on different host tissues. by Thomas Leisen (9248883)

Tumor vessel activity is inhibited by 6a-P peptide. by Tong-Young Lee (250877)

“…Immunohistochemistry result shows that VEGF/KDR complexes are colocalized with vessels (VWF staining) on PBS treated tumor (A; up panel). However, the staining signal is decreased after peptide treatment (A; lower panel). …”

Supplementary Material for: The Progression of the Stargardt Disease Type 4 (ProgStar-4) Study: Design and Baseline Characteristics (ProgStar-4 Report No. 1) by Strauss R.W. (5446388)

Target registration error trend at the scanning depth of 7.4 cm. by David Iommi (8626542)

Results for vertical ground reaction force (VGRF). by Eric Yung-Sheng Su (13015474)

pI7L suppresses the IFN-<i>γ</i>-triggered JAK-STAT signaling pathway. by Meilin Li (1832905)

In vivo data from 1 month (1 Mo), 4 month (4 Mo), and 4 month HF with sustained AF (4 Mo HF+AF) canine groups. by Ingrid M. Bonilla (474103)

Atrial SK expression and calcium transients in chronic HF with and without AF. by Ingrid M. Bonilla (474103)

HT22 viability and LDH release. by Lu Li (14069)